Full Press Release Details
Announces Reschedules 2022 Full Year Results Conference Call
YORK, TORONTO, and HERZLIYA, Israel - April 3, 2023 - InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR)
(dba Canndoc)("InterCure" or the "Company") announced today that it has rescheduled its previously announced
conference call to discuss the company's financial results for the full year ended December 31, 2022.
call was originally scheduled for April 3, 2023 at 4:30 P.M. (Eastren time) but has been rescheduled to April 4, 2023 at 4:30 P.M. (Eastren
time) due to unforeseen circumstances which caused technical issues.
can access the live webcast and conference call through the following link:
InterCure (dba Canndoc)
(dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North
America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to
offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its international
market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale"
model to lead the fastest growing cannabis global market outside of North America.
more information, visit: http://www.intercure.co.
Cohen, Chief Financial Officer